Shakira is turning personal hair struggles into powerful solutions. Shakira Mebarak has transformed her decades-long hair journey into a groundbreaking haircare brand that promises to address the complex needs of diverse hair types, particularly within the Latin community.
The international superstar recently introduced isima, a clinically-backed haircare line that marks a bold new chapter in the beauty industry. Launching exclusively at Ulta Beauty, isima brings a science-driven approach to hair health with its innovative TriModal Method™, a system designed to treat the scalp, cortex, and cuticle for truly transformative results.
A Personal Mission Turned Scientific Innovation
The story behind isima is deeply personal. For years, Shakira struggled to find products that could address her naturally curly, often unpredictable hair. This frustration became the spark for a brand built on both scientific rigor and personal experience. “After four years of working in quietly, I’m proud to finally share this with you,”…
Shakira announced on social media.
Shakira Mebarak said: “I’m so proud of what we are finally able to share with the introduction of isima, which was born out of my own experiences and nurtured for years with the industry’s leading scientific minds.” Her connection to the brand is rooted in her own identity and the shared experiences of those around her.
Shakira Mebarak said: “A big part of my identity has always been my hair. I’m an artist, a performer, a daughter, a mother, and through it all I’ve had these curls that, believe me, have been through a lot.
I’ve watched friends, family, and many other women who like me, spent years trying every new product available to find the right one…
Members-only article
Unlock the rest of this story
Join free to keep reading RetailBoss beauty coverage, industry analysis, and market intelligence.
- Full article access
- Industry analysis
- Free account
Free access. No credit card required. Your account is created after you verify your email.
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.